(6aS)-1,2,9,10-tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline,hydrobromide

Names

[ CAS No. ]:
5996-06-5

[ Name ]:
(6aS)-1,2,9,10-tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline,hydrobromide

[Synonym ]:
C21H25NO4.HBr
(+)-Glaucine hydrobromide
4H-Dibenzo(de,g)quinoline,5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-,hydrobromide,(S)
Glaucine HBr
Glauvent (TN)
d-Glaucine hydrobromide
4H-Dibenzo(de,g)quinoline,5,6,6a,7-tetrahydro-6-methyl-1,2,9,10-tetramethoxy-,hydrobromide,(S)

Chemical & Physical Properties

[ Molecular Formula ]:
C21H26BrNO4

[ Molecular Weight ]:
436.33900

[ Exact Mass ]:
435.10500

[ PSA ]:
40.16000

[ LogP ]:
4.36910

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
HQ1790832
CHEMICAL NAME :
4H-Dibenzo(de,g)quinoline, 5,6,6a,7-tetrahydro-6-methyl-1,2,9,10-tetramethoxy-, hydrobromide, (S)-
CAS REGISTRY NUMBER :
5996-06-5
LAST UPDATED :
199712
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C21-H25-N-O4.Br-H
MOLECULAR WEIGHT :
436.39

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
345 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4367237
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
125 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4367237

Related Compounds

  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 2-(2-Fluoro-5-nitrophenyl)-3-methylbutanoic acid
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • 4-{3-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)ethoxy]propanamido}pentanoic acid
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine